[{"AccountsPayableTradeCurrent_0_Q3_USD":1514000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":32000000.0,"NonoperatingIncomeExpense_1_Q3_USD":-241000000.0,"NonoperatingIncomeExpense_3_Q3_USD":-805000000.0,"NumberOfReportableSegments_3_Q3_Segment":3.0,"OperatingIncomeLoss_3_Q3_USD":1638000000.0,"OperatingIncomeLoss_1_Q3_USD":623000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":425000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":11000000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":507000000.0,"OtherAssetsNoncurrent_0_Q3_USD":518000000.0,"OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_1_Q3_USD":1000000.0,"OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_3_Q3_USD":2000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-195000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-325000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-187000000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-302000000.0,"OtherAssetsCurrent_0_Q3_USD":805000000.0,"OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_1_Q3_USD":-7000000.0,"NetIncomeLoss_3_Q3_USD":576000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":342000000.0,"InventoryNet_0_Q3_USD":4167000000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":1285000000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":631000000.0,"Liabilities_0_Q3_USD":36400000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":47851000000.0,"LiabilitiesCurrent_0_Q3_USD":11825000000.0,"LiabilitiesNoncurrent_0_Q3_USD":24575000000.0,"NetIncomeLoss_1_Q3_USD":292000000.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q3_USD":2300000000.0,"LitigationSettlementExpense_3_Q3_USD":113000000.0,"LongTermDebtCurrent_0_Q3_USD":2386000000.0,"LongTermNotesAndLoans_0_Q3_USD":21037000000.0,"LossContingencyAccrualAtCarryingValue_0_Q3_USD":2009000000.0,"MinorityInterest_0_Q3_USD":984000000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-1671000000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":1277000000.0,"LitigationSettlementExpense_1_Q3_USD":3000000.0,"OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_3_Q3_USD":-21000000.0,"OtherInventoryInTransit_0_Q3_USD":161000000.0,"OtherLiabilitiesCurrent_0_Q3_USD":770000000.0,"RestructuringReserve_0_Q3_USD":128000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-10370000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":3887000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":11778000000.0,"SellingAndMarketingExpense_1_Q3_USD":597000000.0,"SellingAndMarketingExpense_3_Q3_USD":1798000000.0,"SeniorNotes_0_Q3_USD":23491000000.0,"RestructuringCharges_1_Q3_USD":28000000.0,"ShareBasedCompensation_3_Q3_USD":86000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":11451000000.0,"TreasuryStockShares_0_Q3_shares":106000000.0,"TreasuryStockValue_0_Q3_USD":4128000000.0,"ValuationAllowancesAndReservesBalance_0_Q3_USD":4308000000.0,"ValuationAllowancesAndReservesDeductions_3_Q3_USD":10669000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1109000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1109000000.0,"StockholdersEquity_0_Q3_USD":10467000000.0,"RestructuringCharges_3_Q3_USD":96000000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":0.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":723000000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2203000000.0,"OtherOperatingActivitiesCashFlowStatement_3_Q3_USD":-4000000.0,"OtherOperatingIncomeExpenseNet_1_Q3_USD":25000000.0,"OtherOperatingIncomeExpenseNet_3_Q3_USD":73000000.0,"PaymentsForProceedsFromOtherInvestingActivities_3_Q3_USD":33000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":409000000.0,"PrepaidExpenseCurrent_0_Q3_USD":1066000000.0,"ProceedsFromDivestitureOfBusinesses_3_Q3_USD":269000000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-5000000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":172000000.0,"ProceedsFromShortTermDebt_3_Q3_USD":500000000.0,"ProfitLoss_3_Q3_USD":608000000.0,"ProfitLoss_1_Q3_USD":302000000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6040000000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":1475000000.0,"RepaymentsOfShortTermDebt_3_Q3_USD":200000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":222000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":2089000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1103000000.0,"IncreaseDecreaseInOperatingCapital_3_Q3_USD":1881000000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":76000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":2045000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-132000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockParOrStatedValuePerShare_0_Q3_CHF":0.1,"CommonStockSharesAuthorized_0_Q3_shares":2495000000.0,"CommonStockSharesIssued_0_Q3_shares":1209000000.0,"CommonStockValue_0_Q3_USD":57000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":2045000000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":118000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":-3000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-49000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":115000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":306000000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":2093000000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":6234000000.0,"DebtCurrent_0_Q3_USD":2709000000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":355000000.0,"DebtInstrumentFairValue_0_Q3_USD":23431000000.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":187000000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":-9000000.0,"AccountsReceivableNetCurrent_0_Q3_USD":4046000000.0,"AccrualForEnvironmentalLossContingencies_0_Q3_USD":300000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-2620000000.0,"AdditionalPaidInCapital_0_Q3_USD":27529000000.0,"AdjustmentForAmortization_1_Q3_USD":199000000.0,"AdjustmentForAmortization_3_Q3_USD":613000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":26000000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":7000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":86000000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":199000000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":613000000.0,"AssetImpairmentCharges_3_Q3_USD":401000000.0,"Assets_0_Q3_USD":47851000000.0,"AssetsCurrent_0_Q3_USD":12154000000.0,"AssetsFairValueAdjustment_3_Q3_USD":-27000000.0,"AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q3_USD":25000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":119000000.0,"DeferredFinanceCostsNoncurrentNet_0_Q3_USD":69000000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":622000000.0,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q3_USD":910000000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":822000000.0,"Goodwill_0_Q3_USD":20179000000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":432000000.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q3_USD":25600000000.0,"GoodwillImpairmentLoss_1_Q3_USD":0.0,"GoodwillImpairmentLoss_3_Q3_USD":0.0,"GrossProfit_1_Q3_USD":1794000000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":291000000.0,"GrossProfit_3_Q3_USD":5544000000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_3_Q3_USD":295000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q3_USD":26000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":106000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":382000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":833000000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-5000000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":9000000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_1_Q3_USD":21000000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":7832000000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":20292000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":12460000000.0,"DepreciationAndAmortization_3_Q3_USD":1010000000.0,"DerivativeLossOnDerivative_3_Q3_USD":493000000.0,"DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_0_Q3_USD":13000000.0,"DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0_Q3_USD":7000000.0,"DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_0_Q3_USD":32000000.0,"EarningsPerShareBasic_1_Q3_USD":0.26,"EarningsPerShareBasic_3_Q3_USD":0.52,"EarningsPerShareBasicAndDiluted_1_Q3_USD":0.26,"EarningsPerShareBasicAndDiluted_3_Q3_USD":0.52,"EarningsPerShareDiluted_1_Q3_USD":0.26,"EarningsPerShareDiluted_3_Q3_USD":0.52,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-80000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":555000000.0,"EntityCommonStockSharesOutstanding_0_Q3_shares":1103007168.0,"FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_3_Q3_USD":-9000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q3_USD":186000000.0,"FairValueNetAssetLiability_0_Q3_USD":1904000000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":235000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1102000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20211027"}]